Yunyi Li

ORCID: 0000-0002-3100-0498
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Congenital Heart Disease Studies
  • Cardiovascular and Diving-Related Complications
  • Electrowetting and Microfluidic Technologies
  • Coronary Artery Anomalies
  • Tracheal and airway disorders
  • IL-33, ST2, and ILC Pathways
  • Fatty Acid Research and Health
  • Gout, Hyperuricemia, Uric Acid
  • Alzheimer's disease research and treatments
  • Inflammasome and immune disorders
  • 3D Printing in Biomedical Research
  • Dementia and Cognitive Impairment Research
  • Diet and metabolism studies
  • Vascular Anomalies and Treatments
  • Functional Brain Connectivity Studies
  • Eicosanoids and Hypertension Pharmacology
  • Microfluidic and Bio-sensing Technologies

Indiana University – Purdue University Indianapolis
2025

Indiana University School of Medicine
2025

First Affiliated Hospital of Jinan University
2025

Chinese Academy of Medical Sciences & Peking Union Medical College
2024

Institute of Microelectronics
2024

Guangdong Academy of Medical Sciences
2024

Southern Medical University
2024

Guangdong Provincial People's Hospital
2024

Key Laboratory of Guangdong Province
2024

China Medical University
2024

Abstract Drug screening based on in-vitro primary tumor cell culture has demonstrated potential in personalized cancer diagnosis. However, the limited number of cells, especially from patients with early stage cancer, hindered widespread application this technique. Hence, we developed a digital microfluidic system for drug using cells and established working protocol precision medicine. Smart control logic was to increase throughput decrease its footprint parallelly screen three drugs 4 × cm...

10.1038/s41467-024-48616-3 article EN cc-by Nature Communications 2024-05-22

Background Although previous studies have shown that cognitive decline in Alzheimer's disease (AD) is associated with various risk factors, they primarily focused on late-onset AD (LOAD). Objective We aim to evaluate the differential impact of factors between early-onset (EOAD, onset < 65 years) and LOAD (onset [Formula: see text] explore longitudinal effect Apolipoprotein E allele 4 ( APOE ε4) cortical atrophy both cohorts. Methods Using data from 212 EOAD 1101 participants Disease...

10.1177/13872877241307321 article EN other-oa Journal of Alzheimer s Disease 2025-01-12

Abstract Congenital heart disease (CHD) is a structural abnormality of the and/or great vessels and patients with CHD are at an increased risks various morbidities throughout their lives reduced long‐term survival. Eventually, may result in complications including failure, arrhythmias, stroke, pneumonia, sudden death. Unfortunately, exact etiology pathophysiology some remain unclear. Although quality life prognosis have significantly improved following technological advancement, influence...

10.1002/mco2.631 article EN cc-by MedComm 2024-07-01
Coming Soon ...